Royalty Pharma Stock (NASDAQ:RPRX)
Previous Close
$59.02
52W Range
$34.08 - $59.72
50D Avg
$55.49
200D Avg
$45.86
Market Cap
$25.30B
Avg Vol (3M)
$3.75M
Beta
0.42
Div Yield
$0.91 (1.55%)
RPRX Company Profile
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States. Its portfolio consists of royalties on approximately 35 marketed therapies and 20 development-stage product candidates that address various therapeutic areas, such as rare disease, oncology, neuroscience, infectious disease, hematology, and diabetes. The company was founded in 1996 and is based in New York, New York.